CIK 0000886744 · Large accelerated filer
GERON CORP
Sign in to watch- Ticker
- GERN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 752287752
- Phone
- 6504737700
- Business address
- 919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
- Former names
- GERON CORPORATION
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-09 | Spiegel Robert J. Director | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2024-05-09 | Molineaux Susan Director | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2024-05-09 | McDonald John F Director | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2024-05-09 | Bir Dawn Carter Director | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2024-05-09 | LAWLIS V BRYAN Director | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2024-05-09 | O'Farrell Elizabeth G. Director | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2024-03-29 | Spiegel Robert J. Director | Grant or award | +2,462 | $3.30 | $8K | 166,502 |
| 2024-03-29 | Spiegel Robert J. Director | Grant or award | −2,462 | 166,502 | ||
| 2024-02-14 | Feller Faye EVP, CHIEF MEDICAL OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +750,000 | 750,000 | ||
| 2024-02-14 | Kapur Anil EVP, CORP STRATEGY & CCO | Grant or award · Employee Stock Option (Right to Buy) | +750,000 | 750,000 | ||
| 2024-02-14 | Samuels Scott Alan EVP & CHIEF LEGAL OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +850,000 | 850,000 | ||
| 2024-02-14 | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +850,000 | 850,000 | ||
| 2024-02-14 | GRETHLEIN ANDREW J EVP, CHIEF OPERATING OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +1,200,000 | 1,200,000 | ||
| 2024-02-14 | SCARLETT JOHN A CHAIRMAN, PRESIDENT AND CEO | Grant or award · Employee Stock Option (Right to Buy) | +3,000,000 | 3,000,000 | ||
| 2023-12-29 | Spiegel Robert J. Director | Grant or award | +3,406 | 164,040 | ||
| 2023-12-29 | Molineaux Susan Director | Grant or award | +6,220 | 130,527 | ||
| 2023-12-29 | Aggarwal Gaurav Director | Grant or award | +1,970 | 1,970 | ||
| 2023-11-26 | Aggarwal Gaurav Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2023-09-29 | Molineaux Susan Director | Grant or award | +6,191 | 124,307 | ||
| 2023-09-29 | Spiegel Robert J. Director | Grant or award | +3,390 | 160,634 |
Page 5 of 7 · 138 trades